RiverFront Investment Group LLC Invests $779,000 in Cigna Group $CI

RiverFront Investment Group LLC purchased a new position in shares of Cigna Group (NYSE:CI) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 2,832 shares of the health services provider’s stock, valued at approximately $779,000.

Other hedge funds also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Cigna Group by 11.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after purchasing an additional 4,738 shares during the last quarter. Maj Invest Holding A S increased its stake in shares of Cigna Group by 2.4% during the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock worth $121,854,000 after purchasing an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC increased its stake in shares of Cigna Group by 1,016.8% during the 3rd quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock worth $2,453,000 after purchasing an additional 7,748 shares during the last quarter. National Pension Service increased its stake in shares of Cigna Group by 3.2% during the 3rd quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after purchasing an additional 21,203 shares during the last quarter. Finally, Caprock Group LLC acquired a new position in shares of Cigna Group during the 3rd quarter worth $4,124,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE CI opened at $286.14 on Tuesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a fifty day simple moving average of $275.05 and a 200 day simple moving average of $275.57. The company has a market cap of $75.69 billion, a P/E ratio of 12.13, a P/E/G ratio of 1.00 and a beta of 0.30. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is 26.45%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 205,904 shares of company stock valued at $60,277,068 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of several analyst reports. Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research note on Friday, May 1st. TD Cowen increased their price target on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Cantor Fitzgerald upped their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. Finally, Truist Financial upped their price objective on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Cigna Group has an average rating of “Moderate Buy” and a consensus target price of $338.35.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.